AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Blood pressure is regulated by a complex neurohumoral system including the renin-
angiotensin-aldosterone system, natriuretic peptides, endothelial pathways, the sympathetic …

Hypertension (HT) is a modifiable risk factor for life-threatening cardiovascular diseases
(CVDs) including coronary artery disease, heart failure, or stroke. Despite significant …

Background Coronary artery disease (CAD) remains one of the leading causes of mortality
worldwide. We aimed to summarize what is currently known with regard to causal modifiable …

* Writing committee members are required to recuse themselves from voting on sections to
which their specific relationships with industry may apply; see Appendix 1 for detailed …

Background Mendelian randomization (MR) studies suggest a causal effect of iron status on
cardiovascular disease (CVD) risk, but it is unknown if these associations are confounded by …

Heart failure (HF), a clinical syndrome which was designated as a new epidemic in 1997, is
associated with substantial morbidity and mortality and has a considerable impact on health …

Immune checkpoint inhibitors (ICIs) and Janus kinase inhibitors (JAKis) have raised
concerns over serious unexpected cardiovascular adverse events. The widespread …

Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Background: This study aimed to comprehensively analyze research related to hypertension
and atrial fibrillation, 2 common cardiovascular diseases with significant global public health …